Treat to target: a winner strategy in rheumatology. From the past to the future Beyond Rheumatology 2021; 3 (3) : e302 DOI: 10.4081/br.2021.79
EULAR guidelines on ANCA-associated vasculitis in the real life Beyond Rheumatology 2021; 2 (3) : e281 DOI: 10.4081/br.2020.50
Biosimilars: New guns for the treatment of rheumatological patients? Beyond Rheumatology 2019; 1 (1) : e255 DOI: 10.4081/br.2019.3